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Analyses of biological databases such as those of genome, proteome, metabolome etc., have given insights in organization of 
biological systems. However, current efforts do not utilize the complete potential of available metabolome data. In this study, 
metabolome of bacterial systems with reliable annotations are analyzed and a simple method is developed to categorize pathways 
hierarchically, using rational approach. Ninety-four bacterial systems having for each ≥ 250 annotated metabolic pathways were 
used to identify a set of common pathways. 42 pathways were present in all bacteria which are termed as Core/Stage I pathways. 
This set of pathways was used along with interacting compounds to categorize pathways in the metabolome hierarchically. In each 
metabolome non-interacting pathways were identified including at each stage. The case study of Escherichia coli O157, having 433 
annotated pathways, shows that 378 pathways interact directly or indirectly with 41 core pathways while 14 pathways are non-
interacting.  These 378 pathways are distributed in Stage II (289), Stage III (75), Stage IV (13) and Stage V (1) category.  The 
approach discussed here allows understanding of the complexity of metabolic networks. It has pointed out that core pathways 
could be most ancient pathways and compounds that interact with maximum pathways may be compounds with high biosynthetic 
potential, which can be easily identified. Further, it was shown that interactions of pathways at various stages could be one to one, 
one to many, many to one or many to many mappings through interacting compounds. The granularity of the method discussed 
being high; the impact of perturbation in a pathway on the metabolome and particularly sub networks can be studied precisely. 
The categorizations of metabolic pathways help in identifying choke point enzymes that are useful to identify probable drug 




In recent years there has been an exponential growth in the 
number of full genome sequencing projects. This has generated 
huge genome sequence and related data. Organization of data 
related to genome, proteome, metabolome etc., in databases and 
analysis of the data in these databases have given insights in 
organization of biological systems. At each level of organization 
new properties and rules emerge that could not be predicted by 
studying lower levels [1, 2]. For example, studying genes and 
proteins in isolation does not provide information on network 
of genes and proteins. The unique property that emerges by 
studying interacting network of genes and proteins is the 
dynamic interactions among chemical compounds – 
metabolites, substrates etc. Metabolism is an emergent property 
of this dynamic interaction. Various approaches have been used 
to simplify and understand complex network of metabolic 
pathways. This has lead to classification of metabolome by 
implementing different set of rules.  
 
Jeong  et al.,  [3] have shown that the metabolic pathways are 
scale free and highly interconnected. Ma et al., [4] have used 
KEGG LIGAND [5] database to classify the metabolome in a 
fully connected sub-network using substrate and product 
properties. The primary aim of their work was to study 
network properties such as strong component of a network and 
closeness centrality. Another study on metabolic classification 
reported that metabolic networks are organized into highly 
connected topological modules. These modules then combine in 
a hierarchical manner into larger less cohesive units and 
demonstrated that their degree of clustering follows a power 
law  [6]. Further these authors have classified the modules 
depending on the biochemical property such as carbohydrate 
metabolism, nucleotide and nucleic acid metabolism, protein, 
peptide and amino acid metabolism, lipid metabolism etc [6]. 
Ihmels et al., [7] analysed the co-expression pattern of genes and 
revealed strong coordinated regulation of genes involved in BIOINFORMATION  open access 
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individual metabolic pathways. Their analysis demonstrated 
that a clear hierarchical structure exists in metabolic network 
that converges with one of the three modules associated with 
amino acid biosynthesis, protein synthesis and stress. From 
these studies it is difficult to infer global relation between 
metabolic pathways in the organisms. Also none of the above 
studies have used specific metabolic pathway ontology, thus 
making it difficult to unveil unique features of a metabolome. 
Further, non-usage of specific ontology makes it difficult to 
compare the results from different studies.  
 
Handorf  et al.,  [8] introduced the concept of biosynthetic 
potential of a compound and expansion of metabolic network 
depending on the scope of randomly selected seed compounds. 
More recently Azuma et al.,  [9] reported minimal pathway 
maps by analyzing KEGG pathway maps of 30 representative 
genomes. These studies have identified energy conversion, 
amino acid biosynthesis and nucleotide biosynthesis as 
essential or part of the minimal set of metabolic pathways. 
Therefore it is argued that simpler/conserved metabolic 
pathways were present in the primordial cell. However these 
studies do not comment on direct or indirect dependence of rest 
of the pathways on the minimal/conserved pathways. 
Understanding the evolution of present complex metabolic 
network from the primordial set of pathways is difficult and 
thus above studies fail to pinpoint the causality behind 
pathways interactions. None of the above studies fully utilizes 
the potential of enormous metabolic data in large number of 
bacteria available in the post-genomic era. There is a need to 
develop a method that extract knowledge from this large data 
and helps in understanding the organization as well as 
functioning of the organism at higher resolution.  This 
knowledge will help in engineering organism to attain specific 
function, through suitable modification of pathways. A simple 
method is developed with this aim and the results obtained are 
discussed in succeeding sections. 
 
 
Figure 1: Extension of metabolic categories from four 
Core/Stage I pathways belonging to carbohydrate metabolism. 
Nodes in red colour denote non-interacting pathways while 




Reliable and highly curated data from Pune University 
Metabolic Pathway Engineering (PuMPE) resource [10] is used 
in this study. Pathways data for ninety-four bacteria (50 aerobic, 
38 facultative and 6 anaerobic bacteria) having 250 or more 
metabolic pathways was extracted from PuMPE database. 
Further analysis was carried out using this data for each of the 
ninety-four bacteria. Data from archaea are not included in the 
present analysis. 
 
Identification of core pathways (Stage I) 
U1 U2 ......U94 are sets of metabolic pathways in each bacterium 
B1, B2  ...B94 respectively. Core pathways C called Stage I 
pathways are U1∩ U2∩U3∩…..∩U94 =   C 
 
To find out therefore C pathways following approach was used:  
Each pathway has a ‘Unique id’ in PuMPE database. In order to 
identify common identical pathways in ninety-four bacteria 
‘Unique id’ in each bacterium was compared iteratively. The 
presence of pathways with same ‘Unique id’ in each of ninety-
four bacteria represents identical pathways. 42 such identical 
pathways were found to be present in each of these ninety-four 
bacteria. These identical metabolic pathways that are present in 
all bacteria are termed as Core pathways C or Stage I pathways. 
 
Categorization of metabolome according to metabolic 
pathways interactions 
The metabolome is categorized depending upon direct or 
indirect interaction of Core pathways (Stage I) with rest of the 
pathways. To categorize metabolome and assign a stage to the 
pathway in each bacterium following approach is used. Any 
pathway is said to be interacting with other pathway if at least 
one of the compounds – start, intermediate or end product is 
common in two pathways under consideration.  
 
Following algorithm was used to categorize the metabolome 
using above definition of interacting pathways: 1) A set of all 
start, intermediate and end compounds {Cm}i  from set of 
pathways {P}i  belonging to Stage i was prepared; 2) A set of 
pathways categorized as ‘other’ pathways {O}i at Stage i was 
prepared after each stage of categorization of pathways; 3) 
Compounds (start, intermediate or end) in a particular pathway 
from the set of other pathways {O}i were compared with {Cm}i 
and if even a single compound was found to be identical then 
that pathway was categorized to Stage (i+1); 4) This process 
was continued for each pathway in the set {O}i to identify a set 
of interacting pathways {P}i+1 belonging to Stage (i+1); 5) Non-
interacting pathways form the set {O}i+1 pathways of category 
are termed as ‘other’; 6) This process was continued till 
pathways in {O}n do not interact; 7) The initial set or Stage I 
pathways for each bacterium is always a set of core pathways C 
and the starting point of subsequent categorization. 
 
Result & Discussion: 
From 422 bacteria in PuMPE database, ninety-four bacteria have 
≥250 annotated pathways. Among these pathways 42 pathways 
are identical in all bacteria, called Stage I or Core pathways. The 
list of Core pathways (Stage I) is given in Table 1 (see 
supplementary material). BIOINFORMATION  open access 
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As can be seen from Table 1, core pathways include important 
pathways such as amino acid, carbohydrate, lipid and 
nucleotide metabolism. Presence of these pathways as core 
pathways supports the hypothesis that these are primary 
pathways, as suggested by Woese [11], could be the most 
ancient pathways. Thus these 42 pathways are suggested as 
being part of the universal ancestor metabolome. The 
methodology explained in the methods section was applied to 
categorize the pathways in each of the ninety-four bacteria. 
Results of a case study of categorization of metabolome of E.coil 
O157 are discussed below. 
 
Metabolic categorization: a case study of Escherichia coli O157 
Escherichia coli O157 is one of the best-annotated metabolome. In 
this strain of E.coil  433 pathways are annotated. Therefore, 
categorization of these 433 pathways is discussed. Start, 
intermediate and end compounds in each of the 433 pathways 
were extracted from PuMPE database. These were then 
organized in two sets: I - Compounds from 42 Core/Stage I 
pathways and II - Compounds from remaining or other 391 
pathways 
 
If common compounds are present between Stage I and one or 
more remaining pathways, then those pathways were 
considered to have interaction with Stage I pathways. Such 
interacting pathways are called Stage II pathways. In Escherichia 
coli O157, 289 pathways from set of 391 pathways were found to 
interact with 41 core pathways. Thioredoxin pathway in the set 
of core pathway did not interact with any of the 391 pathways 
as there is no compound from this pathway that is common to 
any of the compounds from remaining 391 pathways. 
Thioredoxin pathway is termed as non-interacting.  
 
In next step a set of start, intermediate and end compounds of 
the 289 Stage II pathways was prepared. These compounds 
were then compared with start, intermediate and end 
compounds of each of the remaining 102 pathways of the set 
‘other’ pathways. This comparison gave 75 interacting 
pathways with Stage II. These 75 pathways are categorized as 
Stage III pathways and remaining 27 pathways as other 
pathways. The interaction between 75 pathways of Stage III and 
remaining 27 pathways gave rise to 13 Stage IV pathways. 
Finally Stage IV pathways interact with only one of the 
remaining 14 pathways giving one Stage V pathway namely - 
“Lipid A-core biosynthesis”.  
 
Table 2 (see supplementary material) also points out that at 
every stage there are pathways that do not interact with any of 
the remaining pathways. These are called ‘next stage non-
interacting pathways’. In other words, in the hierarchical 
network of pathways model, these non-interacting pathways 
interact with previous stage pathways but do not interact with 
next stage pathways. For example, Thioredoxin pathway, the 
non-interacting pathway at Stage I do not have any direct or 
indirect impact on any of the ‘other’ metabolic pathways in 
Escherichia coli O157. On the other hand 200 non-interacting 
pathways of Stage II will interact with one or more 41 pathways 
of Stage I and will have no interaction with remaining 102 
pathways belonging to Stage III (75), IV (13), V (1) or non-
interacting (13) pathways. Similar is the case with other non-
interacting pathways that, they will not affect higher stage 
pathways. 
Previously, a set of randomly selected seed compounds from 
KEGG database was used to demonstrate expansion of 
metabolic network [8]. The method described here selects seed 
compounds by following a rational approach and is biologically 
more meaningful. This simple approach of categorization 
allows identification of pathways that will not get impacted 
even if certain pathways are modified or engineered. 
 
The fourteen non-interacting pathways are listed in Table 3 (see 
supplementary material). None of these pathways have a 
single common compound with remaining pathways in the 
metabolome of E.coil O157. In other words substrate and 
catalysing enzymes are unique in these fourteen pathways. 
Identification of such pathways is not easy, though important, 
and may be very good target to engineer specific property of 
the organism. The analysis of these non-interacting pathways 
thus becomes essential. A careful reading of names of pathways 
in Table 3 gives some idea as to why these pathways are present 
but do not interact with each other or any other pathway in 
E.coil O157. 
 
The first three pathways in Table 3 (see supplementary 
material) are responsible for degradation of aldoximes, 
acrylonitrile and catechol respectively, which can enter bacterial 
cell through free diffusion, use of a permease or other transport 
system [12]. Aldoxime, acrylonitrile and catechol are toxic and 
are often discharged into environment by various chemical 
industries. If these compounds are not degraded then they will 
harm environment and can have severe impact on aquatic 
ecology. The capability of degradation of aldoximes and 
acrylonitrile by Escherichia coli O157 is of interest as it may help 
in treatment of nitrile pollution. Similarly, catachols are also 
great environmental concern as they are known to be 
carcinogenic to human beings [12]. Therefore, the three 
degradation pathways 1 to 3 in Table 3 (see supplementary 
material) in Escherichia coli O157 can help in bioremediation of 
contaminated sites. Hence the non-interaction of these 
pathways can be understood, as they seem to have evolved in 
response to the change in environment. 
 
In a similar manner Cis-vaccenate biosynthesis, sulphate 
activation for sulfonation and Cyclopropane fatty acid 
biosynthesis pathways (4 to 6 in Table 3) help the organism to 
survive under stress by producing /utilizing unusual 
compounds. For example Cis-vaccenate is the only unsaturated 
fatty acids found in Escherichia coli O157. It helps in adjusting 
growth and differentiation to differing temperatures.  Sulfate 
activation for sulfonation pathway improves the defence 
mechanism of E.coli, where as the cyclopropane fatty acid 
synthesised in the cyclopropane fatty acid biosynthesis 
pathway protects from acid shock [13]. 
 
Pathways 7-11 Table 3 can be categorized as co-factor 
biosynthesis pathways and are known to be essential for 
viability of an organism [14-16] On the other hand pathways 12 
& 13 Table 3 are electron donor and acceptor pathways where 
as pathways 14 Table 3 is transporter of inorganic nutrient 
namely ammonium. In fact, pathways 7-10 in Table 3 are 
identified as drug target in various bacteria [14-16] and can be 
used as target pathways for designing drug against the diseases 
such as haemorrhagic colitis or haemolytic uremic caused by 
E.coli O157 [17]. BIOINFORMATION  open access 
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From above analysis it is clear that set of non-interacting 
pathways are essential and play very important role in the 
survival, growth and differentiation of an organism.  Evolution 
of these pathways is in response to stress, environmental 
condition or to improve its defence mechanism and have 
therefore carefully chosen enzymes and substrates that have 
unique properties and are not part of other complex networks 
of pathways so that any change in these complex network will 
not have adverse impact on survival or defence mechanism. 
These non-interacting pathways exist in every organism. Since 
no simple tool to identify them was available till this study, 
their importance and roles are not studied in depth or are not 
utilised in engineering organism or pathways. Identification of 
a set of non interacting pathways along with set of identical or 
Stage I pathways is the most important contribution of this 
simple metabolic pathways categorization study described here. 
 
This metabolome categorization approach also allows studying 
in detail complex metabolic networks in the organism. It is clear 
from Table 1 that only one network has highest complexity up 
to Stage V whiles thirteen metabolic networks have four stages. 
To understand the complexity of network a case study of 
pathways belonging to carbohydrate metabolism at Stage I are 
discussed. It can be seen from Table 1 that only four pathways 
namely, gluconeogenesis I, glycolysis I, pentose phosphate 
pathways (non-oxidative) and TCA cycle, can be grouped as 
carbohydrate metabolism.  
 
These four pathways interact with 178 pathways, which are 
termed as Stage II pathways. Out of these 178 pathways only 53 
pathways interact to give 50 Stage III pathways. From these 50 
Stage III pathways, 8 pathways interact to give 9 Stage IV 
pathways, which do not interact further. The same is depicted 
in (Figure 1). It is clear that there is one to  many mapping for 
Stage I to Stage II pathways (4→178) but for at least few 
pathways of Stage II there is many to one mapping to Stage III 
pathways (53→50) as well as for Stage III to Stage IV pathways 
(8—9).  However, the analysis also points out one to one as well 
as many to many mappings of pathways in the complex 
metabolic networks. To understand this complexity, networks 
of two pathways glycolysis I and gluconeogenesis I, belonging 
to the Stage I / Core pathways in the group of carbohydrate 
metabolism, was studied.  
 
It can be seen from (Figure 2), that both these pathways interact 
through compounds Pyruvate and Dihydroxyacetone 
phosphate with Stage II pathways glycine betaine degradation 
and CDP – diacylglycerol biosynthesis I & II. These Stage II 
pathways interact through 1, 2 diacylglycerol -3- phosphate and 
Glycine betaine with Stage III pathways phospholipid 
degradation, choline degradation and glycine betaine 
biosysnthesis I. These three pathways through choline and 
phosphadylcholine interactions give rise to phosphadylcholine 
biosynthesis I pathways - a single pathway (Figure 2). It can 
also be seen that the compound Glycine betaine is common for 
two pathways choline degradation I and glycine betaine 
biosynthesis I. The network and its complexity can be worked 
out to high precision using above-mentioned approach for 
every pathway. Therefore the effect of pathway perturbation on 
the substructure as well as whole metabolome can be 
understood. Modifications of precise nature or engineering of 
metabolome is possible because of the understanding of precise 
connection among pathways and chemical / biochemical 
r e a c t i o n s .  I t  m u s t  b e  k e p t  i n  m i n d  t h a t  t h e s e  n e t w o r k s  a r e  
results of the assumption that pathways given in Table 1 (see 
suplementry material) are at the lowest level. 
 
 
Figure 2: Detailed sub-network of Figure 1 shows the interacting pathways and compounds from Stage I to Stage IV of two core 
pathways - Glycolysis I and Gluconeogenesis I. Interacting compounds are shown in boxes while pathway names are along the 
lines. 
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The occurrences of various types of complex networks not only 
of different hierarchy but also different mappings indicate that 
interacting compounds are used with varied frequency. To 
understand the correlation between number of times the same 
compound is used to connect different pathways and its 
chemical properties an in-depth analysis is necessary. The 
simple analysis of complex network of pathways discussed 
above suggested that few compounds are used more frequently 
in connecting pathways from lower stage to higher stage. 
(Figure 3) shows top 10 compounds from Stage I pathways that 
interact with remaining pathways t o  f o r m  S t a g e II. Pyruvate 
from four Stage I pathways interact with more than 50 Stage II 
pathways, clearly demonstrating the many to many 
relationship. Similarly acetyl-CoA from three Stage I pathways 
interacts with more than 40 Stage II pathways. As can be seen 
from (Figure 3), there is a sharp drop in the number of Stage II 
pathways that interact with compounds from Stage I. This point 
out that pyruvate and acetyl-CoA play a major role in 
connecting pathways from Stage I to Stage II. It is clear that 
removal or reduction in supply of metabolite like pyruvate or 
acetyl-CoA will have immense impact on the metabolome of the 
E.coli 0157. Many pathways will get affected at Stage II and thus 
those that are connected to them at higher stages will also be 
affected. List of such pathways can be easily determined 
because of the approach used here. In short, the approach of 
metabolic categorization discussed here pinpoints the role of 
compounds in connecting metabolic pathways and expansion 
of network. Also one can study the impact of removal of a 




Figure 3: Top 10 interacting compounds form Stage II 
pathways. Here x-axis represents the common compounds 
between Stages I and II. While y-axis represents the number of 
Stage II pathways with which the compound interacts. 
 
A similar analysis for compounds from Stage II interacting to 
form Stage III pathways revealed no over representation of a 
particular compound. Among the top 10 interacting 
compounds, three compounds viz., dimethylbenzimidazole, 
UDP-D-glucose and menaquinol, which belong to one Stage II 
pathway, interact with five Stage III pathways. In this case one 
to many relationship is evident. The situation did not differ 
when we studied compounds from Stage III interacting to form 
Stage IV. However the compound viz., KDO2-lipid IVA from 
Stage IV interact to form Stage V Lipid–A core pathway, an 
example of one to one relationship as it belongs to one Stage IV 
pathway and interacts with one Stage V pathway. This shows 
that as the level of categorization increases the metabolites 
become more pathway specific.  
 
It is clear from above analysis that compounds that connects 
lower level to higher level of pathways becomes specific as the 
level of pathways connectivity increase. For example, pyruvate 
interacts with fifty-one Stage II pathways through Stage I 
pathways. On the other hand highest connectivity for Stage II to 
Stage III is five and Stage III to Stage IV is four. However, one 
Stage IV pathway interacts with only one Stage V pathway. 
Morowitz  [18] has identified compounds such as pyruvate, 
acetyl – CoA, L-glutamate, succinate and oxaloacetate as a part 
o f  c o r e  m e t a b o l o m e  a n d  t h e y  a r e  r e p o r t e d  t o  h a v e  h i g h  
biosynthetic potential [19]. It can be seen from (Figure 3) that 
these entire compounds are interacting with Stage I and Stage II 
pathways large number of times, indicating the validation of 
the approach used in this study. In fact as mentioned earlier the 
granularity being very high, this type of analysis allows 




A very simple approach of categorization of metabolome has 
helped to identify most of the primordial pathways. The 
categorization approach provides a framework to understand 
global pattern of metabolic organization. Analysis of metabolic 
categories revealed compounds with high connectivity that 
plays an important role in maintaining the complex network of 
metabolome. For the first time the categorization has helped to 
identify precise sub group of pathways that may be affected 
due to perturbations in a particular pathway. The 
categorization of pathways is useful in identifying choke point 
enzymes by analyzing the non-interacting pathways at each 
stage. These choke point enzymes can further be used to 
identify probable drug targets. The process of categorization 
being simple and objective has been used to categorize 
metabolome of ninety-four well-annotated bacteria and is 
available at http://115.111.37.202/mpe/ 
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Table 1: Core/Stage I pathways in Bacteria 
Amino-Acid-Biosynthesis Lipid  Metabolism 
Alanine Biosynthesis I  Fatty Acid &Beta;-Oxidation I 
Arginine Biosynthesis II (Acetyl Cycle)  Fatty Acid Elongation -- Saturated 
Cysteine Biosynthesis I  Fatty Acid Biosynthesis Initiation III 
Glutamine Biosynthesis I   
Glycine Biosynthesis I  Nucleotide Metabolism 
Histidine Biosynthesis    Adenosine Nucleotides De Novo Biosynthesis 
Isoleucine Biosynthesis I (From Threonine)  Guanosine Nucleotides De Novo Biosynthesis 
Leucine Biosynthesis  Pyrimidine Deoxyribonucleotides De Novo Biosynthesis 
Methionine Biosynthesis I  Pyrimidine Ribonucleotides Interconversion 
Phenylalanine Biosynthesis I  Uridine-5'-Phosphate Biosynthesis 
Proline Biosynthesis I   
Serine Biosynthesis  Others 
Threonine Biosynthesis From Homoserine  Trna Charging Pathway 
Tryptophan Biosynthesis  Cardiolipin Biosynthesis I 
Valine Biosynthesis  Chorismate Biosynthesis I 
Tyrosine Biosynthesis I  Flavin Biosynthesis I (Bacteria) 
Homoserine Biosynthesis  Tetrahydrofolate Biosynthesis 
  PRPP Biosynthesis I 
Carbohydrate Metabolism  UDP-N-Acetyl-D-Glucosamine Biosynthesis I 
Gluconeogenesis I  Homoserine Biosynthesis 
Glycolysis I  Thioredoxin Pathway 
Pentose Phosphate Pathway (Non-Oxidative Branch)  Acetyl-Coa Biosynthesis (From Pyruvate) 
TCA Cycle  Superoxide Radicals Degradation 
  
Cofactor-Biosynthesis   
Coenzyme A Biosynthesis   
S-Adenosylmethionine Biosynthesis   
 
Table 2: Categorization of metabolic pathways in EcoO157Cyc 
Sr.No Metabolic  Categories  Count  Interacting  Next Stage Non-interactors 
1  Stage I pathways  42  41  1 
2  Stage II pathways  289  89  200 
3  Stage III pathways  75  12  63 
4  Stage IV pathways  13  1  12 
5  Stage V pathways  1  0  1 
7 Non-interacting  pathways  13  0  13 
8 Total  Pathways  433 143  290 
 
Table 3: List of non-interacting pathways in EcoO157Cyc 
Sr.No Non-interacting  pathways 
1 Aldoxime  degradation 
2 Acrylonitrile  degradation 
3 Cis-vaccenate  biosynthesis 
4  Catechol degradation to ß-ketoadipate 
5  Cyclopropane fatty acid (CFA) biosynthesis  
6  Sulfate activation for sulfonation 
7  Glycine cleavage complex biosynthesis 
8  Biotin-carboxyl carrier protein assembly 
9  Acyl carrier protein metabolism 
10 Thioredoxin  pathway 
11  Lipoate salvage and modification 
12 Sulfite  oxidation  III 
13  Thiosulfate disproportionation III (rhodanese) 
14 Ammonium  transport 
 
 